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Summary : In organotypic corticostriatal and hippocampal slice cultures from
rat brain, 3-hydroxyglutaric acid but not glutaric and glutaconic acids induced
neurodegeneration by activation of NMDA receptors. Electrophysiological
investigations (Xenopus laevis oocytes expressing glutamate receptors ; rat
mixed cortex culture) revealed no direct interaction of 3-hydroxyglutaric acid
with glutamate receptors. We speculate that 3-hydroxyglutaric acid induces a
mild energy deprivation that interferes with the voltage-dependent Mg2`-block
of NMDA receptors.
We investigated whether glutaric, 3-hydroxyglutaric (3-OH-glutaric), and/or gluta-
conic acids produce glutamate receptor-mediated neurotoxicity in corticostriatal,
cortical and hippocampal slice cultures from postnatal rat brain.
Glutamate receptors fall principally into two broad categories : the ionotropic
receptors that are coupled to ion channels and the metabotropic receptors that
e†ect signal transduction via activity of G-protein-linked enzymatic processes.
Within each broad family, numerous receptor subtypes have been identiÐed. The
ionotropic receptors are divided into two families, the NMDA receptors interacting
with N-methyl-D-aspartate and the non-NMDA receptors preferentially activated
by either kainate or by AMPA. All ligand-gated ion channels are permeable to
sodium. The NMDA receptors are especially permeable to calcium and, in contrast
to other glutamate receptors, possess a voltage-dependent Mg2`-block.
Glutamate receptors play a physiological role in excitatory neurotransmission
and in brain maturation (synaptogenesis, dendritic growth) but also in pathological
mechanisms (Olney 1993 ; Bittigau and Ikonomidou, 1997).
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The concept of excitotoxicity describes the potential cell damage induced by excit-
atory amino acids like glutamate via NMDA and non-NMDA receptors (Olney
1980). Morphologically, a massive swelling and vacuolization of the cytoplasm of
postsynaptic neurons due to sodium and water inÑux is observed. A secondary
increase of intracellular calcium concentrations due to inÑux and release from intra-
cellular stores with inhibition of ATP-synthase, activation of proteases and lipases
and activation of nitric-oxide synthase is thought to lead to cell death (Olney 1993,
Bittigau and Ikonomidou 1997). Most recently it was shown (McDonald et al 1998)
that the activation of the AMPA-receptors may also induce degenerationGluR2/R3
of glial cells.
Excessive activation of glutamate receptors can be mediated by either elevated
agonist concentrations or cellular energy depletion even in the presence of normal
agonist concentrations. Under resting conditions, the glutamate concentration in
the extracellular space is lower by several factors than in the postsynaptic cyto-
plasm. The gradient is maintained by distinct carriers. With lack of energy, the
glutamate carriers may not function properly or may even reverse their operation
and release glutamate into the extracellular space, leading to activation of di†erent
glutamate receptor subtypes. Neurodegeneration with release of glutamate enhances
this mechanism. There is evidence that the acute degenerative changes following
status epilepticus, hypoglycinaemia and cerebral ischaemia may partly result from
endogenously released excitatory amino acids (Nicholls and Attwell 1990). The in
vitro work of Henneberry and colleagues (1989) suggested that cellular energy deÐ-
cits may lead to activation of the NMDA channel by a reduction of the resting
membrane potential : this induces a release of the voltage-dependent Mg2`-block of
the channel and allows ions to enter the cell persistently. This hypothesis is sup-
ported by experimental results that show that the mitochondrial toxins MPP
(Turski et al 1991), 3-nitropropionic acid (Ludolph et al 1992) and cyanide (Zeevalk
and Nicklas 1991, 1992) induce morphological changes comparable to those associ-
ated with excitotoxic damage.
Metabolic disorders that are good candidates for excitotoxicity are sulphite-
oxidase deÐciency and homocystinuria. Olney and colleagues (1971) reported that
cysteine S-sulphate induces excitotoxic cell damage and we have recently shown that
homocysteic and homocysteine sulphinic acids activate di†erent glutamate receptor
subtypes (Flott-Rahmel et al 1998).
Several Ðndings cause us to speculate that excitotoxic mechanisms also may play
a role in glutaric aciduria type I. Acute encephalopathic crises, brain/brainstem
ganglia oedema and urinary excretion of lactate and dicarboxylic acids indicate
mitochondrial damage or energy crisis (Gregersen and Brandt 1979). Neuronal
degeneration is found in brain areas with high glutamate receptor density, and post-
synaptic vacuolization of neurons has been described (Goodman et al 1977 ; So†er
et al 1992). Glutaric and hydroxyglutaric acid inhibit the activity of glutamate
decarboxylase with a of 1È3 mmol/L, the range of cerebral glutaric acid concen-Ki
trations found in brain tissue of patients (Stokke et al 1976 ; Taberner et al 1977).
Reduced activity of glutamate decarboxylase as well as reduced GABA concentra-
tions were found in one patient, but surprisingly only in brainstem ganglia, using
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control values from the literature (Leibel et al 1980). At higher concentrations (KiD
glutaric acid inhibits the uptake of glutamate into synaptosomes10 mmol/L),
(Bennett et al 1973). In addition, glutaric acid has a similar structure to glutamate
(Watkins 1991).
MATERIAL AND METHODS
Organotypic slice cultures : Hippocampus, motor cortex or striatum with overlying
cortex slices were prepared of 6-day-old Wistar rats (Baker et al., 1992 ; Ga hwiler,
1981). The tissue was cut into 350 km thick slices with a McIlwain tissue chopper
and incubated in Minimum Essential Medium (MEM) for 30 min at 4¡C.
The slices were cultivated on membranes as described by Stoppini and colleagues
(1991) using either membranes from Nunc (0.2km) or from Millipore (0.4 km) that
inserted into 6-well culture dishes. Although both membrane types were suitable for
culturing the slices, Nunc membranes produced no background Ñuorescence during
propidium iodide staining. Millipore membranes, however, were easier to handle for
sectioning. The culture medium consisted of 50% MEM/HanksÏ balanced salt solu-
tion (Frotscher and Heimrich 1993) that does not contain additional glucose. This
medium was found to give better culture results compared with other media tested
(Ga hwiler 1984 ; Vornov et al 1991) as examined by propidium iodide staining.
LDH measurement, described as an alternative for estimation of cell damage (Koh
and Choi 1987), was not found to be sensitive enough to reÑect cell damage in our
culture system.
Administration of glutamate receptor agonist or metabolites : Short-term incubation
experiments with glutamate receptor agonists were performed in HanksÏ balanced
salt solution (Vornov et al 1991) containing either glutamate (100 kmol/L), or
kainate (100 kmol/L), or NMDA plus glycine (100kmol/L ] 10 kmol/L) using slices
that had been cultivated for 7 days. After 30 min incubation with agonists, cells were
transferred to serum-free medium (75% MEM, 25% BME, and 2 mmol/L
glutamine) for a 24 h recovery period. Incubations in the presence of glutaric acid
(Sigma), 3-OH-glutaric acid, and glutaconic acid (Fluka) (1È5 mmol/L each) were
performed in either HBSS or in HBSS without glucose and Mg2` for 4 h followed
by 24 h of recovery. 3-OH-Glutaric acid was synthesized from its dimethyl ester
(Aldrich) by alkaline hydrolysis (purity [ 97%, GC-MS).
In protection experiments, cultures were pretreated with the noncompetitive
NMDA receptor antagonist MK-801 (20 kmol/L) and the non-NMDA receptor
antagonist CNQX (10 kmol/L) for 20 min prior to co-incubation with the respective
agonists/metabolites. Long-term experiments were started by adding the metabolites
directly to the culture medium at day 1 or 3 of cultivation (for 7 days) or day 7 of
cultivation. The medium was changed every second day.
Nuclei of degenerating cells were visualized by propidium iodide (Sigma) staining
(Vornov et al 1991).
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Examination of energy levels : The e†ects of glutaric acid, 3-OH-glutaric acid and
glutaconic acid (1È5 mmol/L) on ATP levels were tested in the absence or presence
of 3-nitropropionic acid (10 kmol/LÈ1 mmol/L). Incubation times were 4 h and 24 h.
ATP and creatine phosphate levels were examined using a bioluminescence assay
(Lundin et al 1976).
The activity of the respiratory chain enzymes was measured as described by Das
(1998).
Glutaryl-CoA dehydrogenase activity in cultures and tissue concentrations of glutaric
acid : Glutaryl-CoA dehydrogenase activity was examined in organotypic striatal,
cortical and hippocampal cultures as well as in uncultured brain tissue by measure-
ment of release from [1,5-14C]glutaryl-CoA (Christensen 1983). Enzyme activ-CO2
ity in organotypic cultures was relatively high compared with tissue that had not
been in culture. Enzyme activities (kmol/h per g protein) were as follows : (a) in
cultured tissue, striatal 8.95 (SD 0.78), cortical 8.75 (SD 0.21), hippocampal 10.1 (SD
0.61) ; (b) in uncultured tissue, striatum 3.85 (SD 0.39), cortex 2.2 (SD 0.62), hippo-
campus 3.58 (SD 1.16), n \ 3 each.
Glutaric acid concentrations were measured using stable-isotope dilution gas
chromatographyÈmass spectroscopy (Jakobs 1989). Although glutaryl-CoA dehy-
drogenase is expressed in organotypic slice cultures, incubation with glutaric acid
(1 mmol/L, 4 h or 10 days) resulted in tissue concentrations of glutaric acid up to
300 kg/g wet weight, which is higher than that measured in brain autopsy material
derived from GA I patients (88È165 kg/g ; Goodman and Frerman 1995). These Ðnd-
ings indicate, that although glutaryl-CoA dehydrogenase activity is expressed, incu-
bation with glutaric acid leads to elevated metabolite concentrations within cell
cultures.
Histological observations : For histological analysis, slice cultures on Millipore
membranes were Ðxed in KarnovskyÏs solution (2.2% glutaraldehyde and 2.5%
paraformaldehyde in 0.1 mol/L phosphate bu†er, pH 7.35). The tissue/membrane
was postÐxed in dehydrated in alcohol, and embedded in Epon. SemithinOsO4 ,
horizontal sections were cut starting from the surface of the slices. Sections were
stained with toluidine blue for morphological orientation and examined by light
microscopy.
Electrophysiological investigations : To investigate whether glutaric acid, 3-OH-glu-
taric acid, and glutaconic acid exhibit any inÑuence on glutamate receptors, oocytes
of Xenopus laevis were injected with mRNA isolated from neocortical rat brain (day
21, including frontal brain ; Mussho† et al 1994). Expression of glutamate receptors
was tested by electrophysiological measurements in bu†er supplemented with either
NMDA plus glycine (100kmol/L] 10 kmol/L) or AMPA (100 kmol/L) or kainate
(100 kmol/L). The e†ects of glutaric, 3-OH-glutaric and glutaconic acid were tested
by adding these substances (100 kmol/L, 1 mmol/L, 3 mmol/L) to the medium in the
absence or presence of the respective glutamate receptor agonists. Membrane cur-
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rents were measured using the conventional two-electrode voltage clamp technique.
The holding potential was [ 70 mV.
RESULTS
A 30 min incubation of cortical/corticostriatal cultures with glutamate (1 mmol/L),
kainate (100 kmol/L) or NMDA (100 kmol/L) followed by a period of 24 h of
recovery resulted in massive cell damage. The same results were obtained in hippo-
campal cultures incubated with glutamate (1 mmol/L), kainate (100kmol/L) and
NMDA (100 kmol/L). After 30 min incubation (24 h recovery), similar lesion patterns
to those described for hippocampal roller cultures (Tasker et al 1992 ; Vornov et al
1991) could be observed. Cell death could be attenuated by co-incubation of the
cultures with MK 801 (20kmol/L) or CNQX (10kmol/L), indicating that glutamate
receptor activation was involved.
Incubation of cortical/corticostriatal and hippocampal slice cultures with glutaric
acid or glutaconic acid (1È5 mmol/L) did not lead to remarkable propidium iodide
staining. This was found for both short term (4 h) and long-term incubation (10
days) experiments.
In contrast, incubation of corticostriatal and hippocampal cultures with 3-OH-
glutaric acid for more than 4 h exhibited a dose-dependent neurotoxic e†ect as
assessed by propidium iodide staining. Toxicity in hippocampal cultures appeared
at concentrations of 1.5 mmol/L 3-OH-glutaric acid (Figure 1b). With increasing
concentration (3 mmol/L), the e†ect became more prominent (Figure 1c) and was
accompanied by total disintegration of the slice culture (5 mmol/L). Propidium
iodide label was completely attenuated by co-incubation with MK 801, indicating
that cell death is mediated by the activation of NMDA receptors. Incubation of
corticostriatal cultures with 3-OH-glutaric acid again led to a dose-dependent
neurodegeneration, starting within the striatum at medium concentrations of
1.5 mmol/L. Morphologically, 3-OH-glutaric acid induced massive swelling and loss
of neurons (Figure 2) (Flott-Rahmel et al 1997).
With simple immunostaining (glutamate decarboxylase), no speciÐc degeneration
of GABAergic neurons was found.
At high concentrations (5 mmol/L) and incubation for more than 24 h, glutaric,
3-OH-glutaric and glutaconic acids produced cell swelling within the glia layer
which could not be prevented by co-incubation with NMDA receptor and non-
NMDA receptor antagonists (MK 801, CNQX) (Figure 3).
Administration of 3-OH-glutaric and glutaconic acid led to a 10È30% reduction
of ATP levels in corticostriatal/hippocampal slice cultures.
Treatment of corticostriatal/hippocampal slices with 1 mmol/L 3-nitropropionic
acid, an inhibitor of complex II of the respiratory chain, led to intense propidium
iodide staining and lowered ATP levels by about 80% of control values. Cell degen-
eration could be attenuated by co-incubation with MK 801 (20 kmol/L). A com-
bination of subtoxic concentrations of 3-nitropropionic acid (10 kmol/L ; D 25%
reduction of intracellular ATP levels) with 3-OH-glutaric and glutaconic acids (1È
J. Inher. Metab. Dis. 22 (1999)
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Figure 2 Hippocampal culture, vacuolation of neurons following incubation with 3 mmol/L
3-OH-glutaric acid. Toluidine blue staining ]500
5 mmol/L) did not enhance the neurotoxicity or lead to a further reduction of ATP
levels.
Incubation of 10-day-old mixed cortex cultures from neonatal rats with 3-OH-
glutaric acid signiÐcantly reduced the activity of complexes II and V of the respir-
atory chain, whereas incubation with glutaric acid reduced the activity of complex II
only (Table 1). In this culture system, incubation with glutaric and 3-OH-glutaric
acid did not reduce the intracellular ATP level, presumably because the cells were
Table 1 Mixed cortex culture. Activitya of the respiratory chain
Glutarate 3-OH-Glutarate 3-OH-Glutarate
Complexb Controls (4 mmol/L ) (4 mmol/L ) (2 mmol/L )
V 285 ^ 95 295 ^ 98 175 ^ 85* 222 ^ 105**
II ] III 4 ^ 1 0 0 0
a nmol/min/mg protein. The results give the mean value of 8 culture dishes each
b The activity of complex I and IV was found to be normal in the presence of di†erent metabolites
* p \ 0.01 ; ** p \ 0.02
J. Inher. Metab. Dis. 22 (1999)
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Figure 3 Hippocampal culture following incubation with 3-OH-glutaric acid (5 mmol/L),
demonstrating vacuolation of neuron layers and vacuolar degeneration of glia cells (arrow).
]25
not maximally stimulated (Table 2). Preliminary data indicate that 3-OH-glutaric
acid speciÐcally reduces the intracellular creatine phosphate levels (Table 2).
Administration of glutaric, 3-OH-glutaric and glutaconic acids at concentrations
of 100 kmol/L, 1 mmol/L or 3 mmol/L did not evoke membrane currents in frog
oocytes expressing di†erent glutamate receptors. Simultaneous administration of the
metabolites with glutamate receptor agonists did not change agonist-induced mem-
brane currents (Figure 4).
Table 2 Mixed cortex culture : ATP/CP concentrationsa
Glutarate 3-OH-Glutarate 3-OH-Glutarate
Compoundb Control (4 mmol/L ) (4 mmol/L ) (2 mmol/L )
ATP 11^ 5 10 ^ 4 7 ^ 3 9 ^ 2
CP 7^ 5 7 ^ 5 2 ^ 2* 3 ^ 3**
a nmol/mg protein. The results give the mean value of 5 culture dishes each
b ADP concentrations were found to be normal in the presence of di†erent metabolites
* p \ 0.02 ; ** p \ 0.05
J. Inher. Metab. Dis. 22 (1999)
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Figure 4 E†ects of NMDA (100 kmol/L plus 10 kmol/L glycine), AMPA (100kmol/L), glu-
taric acid (GA, 1 mmol/L), 3-OH-glutaric acid (3-OH, 1 mmol/L) and glutaconic acid (GC,
1 mmol/L) on glutamate receptor currents in frog oocytes
In additional experiments using mixed cortex cultures (10 days) of postnatal rats,
we showed (a) that only 3-OH-glutaric acid is enhancing the network activity ; (b)
that enhanced network activity can be prevented by NMDA receptor antagonists
only ; (c) that 3-OH-glutaric acid does not bind to NMDA receptors, (d) does not
modulate glutamate binding to these receptors, (e) is not interacting with GABAer-
gic receptors and (f) is presumably not leading to enhanced presynaptic glutamate
concentrations, as can be taken from results obtained with autopsies (unpublished
data).
DISCUSSION
Tissue slice cultures are the most physiological system to test glutamate toxicity, as
they preserve the cytoarchitecture for more than 2 weeks with typical cell contact,
transmitter interaction and function of glutamate carriers. Thus, as compared to
cultivated hippocampal neurons, the glutamate toxicity is several times lower
(Henneberry et al 1989).
Our results give evidence that 3-OH-glutaric acid is the relevant neurotoxin in
glutaric aciduria type I. The metabolite induces neurodegeneration by activation of
NMDA receptors, but does not directly interact with glutamate receptors as was
shown electrophysiologically in di†erent cell systems. In addition, it was found that
3-OH-glutaric acid does not modify the binding of glutamate to receptors, does not
interact with GABAreceptors and is presumably not producing enhanced presynap-
tic glutamate concentrations. The results do not exclude reduced presynaptic GABA
J. Inher. Metab. Dis. 22 (1999)
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concentrations. Diminution of GABA-mediated inhibitory neurotransmission is
thought to lead to neurodegeneration in the calf model of maple syrup urine disease
(Dodd et al 1992).
Our results do not explain, how raised concentrations of 3-OH-glutaric acid
produce an indirect activation of NMDA receptors. Reduced cellular ATP levels,
interfering with the voltage-dependent Mg2`-block of NMDA receptors, are pre-
sumably not the crucial mechanism as they were obtained in slice cultures by incu-
bation with glutaconic or 3-OH-glutaric acid. Preliminary data indicate that 3-OH-
glutaric acid speciÐcally reduces the intracellular creatine phosphate levels. Ko lker
and colleagues (1998) demonstrated that the toxicity of 3-OH-glutaric acid is medi-
ated by the NR2B subtype of NMDA receptors. These results may explain the
regional distribution of neurodegeneration as found in patients (Monaghan and
Cotman 1985 ; Wenzel et al 1997). Again this group did not Ðnd any direct ligandÈ
receptor interaction. The regional distribution of cell death in hippocampal slices of
di†erent ages might be explained by an age-dependent expression of NMDA recep-
tor subtypes.
Glutaric, glutaconic and 3-OH-glutaric acids additionally produce a vacuolar
glial degeneration that in our hands could not be prevented by glutamate receptor
antagonists. Excitotoxic mechanisms leading to degeneration of oligodendrocytes
were recently described by McDonald and colleagues (1998).
It has been speculated that another glutamate receptor agonist with a high excito-
toxic potential, quinolinic acid, may be responsible for neurodegeneration in glu-
taric aciduria type I (Heyes 1987), but quinolinic acid concentrations were found to
be normal in the CSF of patients (Land et al 1992).
Our results allow us to speculate that mild energy deprivation is indirectly leading
to activation of NMDA receptors. The functional properties, including susceptibility
to glutamate or energy deprivation of di†erent NMDA receptor subtypes, seem to
be age dependent (Monyer et al 1994).
We believe that these results are the Ðrst steps in understanding the basic pathol-
ogy of the disease and, if conÐrmed, will open a therapeutic window.
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